Contact us

532 Results:

Sort By:

Enrollment completed in clinical trial evaluating effect of exclusive human milk diet including a specialty fortifier in term infants born with single ventricle physiology

Type: Press Releases

Topic(s): Single Ventricle Congenital Heart Defects (SVP )

Understanding the nutritional needs of premature babies: A discussion with Dr. Melinda Elliott

Type: Prolacta in the News

Topic(s): Bronchopulmonary Dysplasia (BPD) Feeding Intolerance Late-Onset Sepsis Necrotizing Entercolitis (NEC) Parents

Know your NICU nutrition: The importance of appropriate nutrition in the NICU

Type: Prolacta in the News

Topic(s): Bronchopulmonary Dysplasia (BPD) Late-Onset Sepsis Necrotizing Entercolitis (NEC) Parents Retinopathy of Prematurity (ROP)

Guided by evidence-based care in the use of human milk-based nutrition in the NICU: Learning from the past

Type: Prolacta in the News

Topic(s): Quality & Safety

Sinai Chicago is first safety net NICU to address health inequity gap by adopting an EHMD

Type: Prolacta in the News

Topic(s): Company Feeding Intolerance Mortality

Human breastmilk fortifiers may ward off eye disease in premature babies, finds Prolacta-backed study

Type: Prolacta in the News

Topic(s): Retinopathy of Prematurity (ROP)

Four studies showed Prolacta Bioscience’s 100% human milk-based fortifiers reduced retinopathy of prematurity (ROP) in premature infants

Type: Press Releases

Topic(s): Retinopathy of Prematurity (ROP)

Baby Crew achieves healthy growth with Prolacta's fortifiers

Type: Parent Stories

Topic(s): 22-27 weeks (extremely premature) Parents

Gloria Crockett, senior director of quality

Type: Employee Stories

Topic(s): Company Quality & Safety

Not finding the reference you’re looking for?

Email us at info@prolacta.com